Clinical Trial Update: Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of gemcitabine and trabectedin in leiomyosarcoma and liposarcoma has completed. The study explored safety and prelimina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma

Drugs mentioned

• Gemzar (gemcitabine)
• Yondelis (trabectedin)

Snippet

Sponsor: Heidelberg University | Conditions: Leiomyosarcoma, Liposarcoma | Phase 1 | Status: COMPLETED